Literature DB >> 11749630

Total synthesis of microtubule-stabilizing agent (-)-laulimalide.

A K Ghosh1, Y Wang, J T Kim.   

Abstract

An enantioselective first total synthesis of laulimalide (1) is described. Laulimalide, a remarkably potent antitumor macrolide, has been isolated from the Indonesian sponge Hyattella sp. and the Okinawan sponge Fasciospongia rimosa. Laulimalide represents a new class of antitumor agents with significant clinical potential. The synthesis is convergent and involved the assembly of C(3)-C(16) segment 4 and C(17)-C(28) segment 5 by Julia olefination. The sensitive C(2)-C(3) cis-olefin functionality was installed by Yamaguchi macrolactonization of a hydroxy alkynic acid followed by hydrogenation of the resulting alkynoic lactone over Lindlar's catalyst. Initial attempts of intramolecular Still's variant of Horner-Emmons olefination between the C(19)-phosphonocetate and C(3)-aldehyde provided a 1:2 mixture of cis- and trans-macrolactones. The trans-isomer was photoisomerized to a mixture of cis- and trans-isomers. The other key steps involved ring-closing olefin metathesis to construct both dihydropyran units, stereoselective anomeric alkylation to functionalize the dihydropyran ring, stereoselective reduction of the resulting alkynyl ketone to set the C(20)-hydroxyl stereochemistry, and a novel Julia olefination protocol for the installation of the C(13)-exo-methylene unit. The sensitive epoxide at C(16)-C(17) was introduced in a highly stereoselective manner by Sharpless epoxidation at the final stage of the synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749630     DOI: 10.1021/jo010854h

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  20 in total

1.  Total synthesis of laulimalide: synthesis of the northern and southern fragments.

Authors:  Barry M Trost; W Michael Seganish; Cheol K Chung; Dominique Amans
Journal:  Chemistry       Date:  2012-02-03       Impact factor: 5.236

2.  An enantioselective synthesis of the C1-C9 segment of antitumor macrolide peloruside A.

Authors:  Arun K Ghosh; Jae-Hun Kim
Journal:  Tetrahedron Lett       Date:  2003-04-24       Impact factor: 2.415

3.  Synthesis of Linear (Z)-α,β-Unsaturated Esters by Catalytic Cross-Metathesis. The Influence of Acetonitrile.

Authors:  Elsie C Yu; Brett M Johnson; Erik M Townsend; Richard R Schrock; Amir H Hoveyda
Journal:  Angew Chem Int Ed Engl       Date:  2016-10-10       Impact factor: 15.336

4.  Synthetic studies of microtubule stabilizing agent peloruside A: an asymmetric synthesis of C10-C24 segment.

Authors:  Arun K Ghosh; Jae-Hun Kim
Journal:  Tetrahedron Lett       Date:  2003-09-13       Impact factor: 2.415

5.  A frustrated-Lewis-pair approach to catalytic reduction of alkynes to cis-alkenes.

Authors:  Konstantin Chernichenko; Adám Madarász; Imre Pápai; Martin Nieger; Markku Leskelä; Timo Repo
Journal:  Nat Chem       Date:  2013-07-07       Impact factor: 24.427

6.  Enantioselective syntheses of the proposed structures of cytotoxic macrolides iriomoteolide-1a and -1b.

Authors:  Arun K Ghosh; Hao Yuan
Journal:  Org Lett       Date:  2010-07-16       Impact factor: 6.005

7.  Enantioselective total synthesis and structural assignment of callyspongiolide.

Authors:  Arun K Ghosh; Luke A Kassekert; Joseph D Bungard
Journal:  Org Biomol Chem       Date:  2016-12-07       Impact factor: 3.876

8.  Evaluating transition-metal-catalyzed transformations for the synthesis of laulimalide.

Authors:  Barry M Trost; Dominique Amans; W Michael Seganish; Cheol K Chung
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

9.  Alcohol-assisted phosphine catalysis: one-step syntheses of dihydropyrones from aldehydes and allenoates.

Authors:  Gardner S Creech; Ohyun Kwon
Journal:  Org Lett       Date:  2008-01-04       Impact factor: 6.005

Review 10.  Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.

Authors:  Arun K Ghosh
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.